Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus

Pradeep Bhandari, Adrian C. Bateman, Raj L. Mehta, Bernard S F Stacey, Penny Johnson, Ian A. Cree, Federica Di Nicolantonio, Praful Patel

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: COX-2 expression in tumour cells has been associated with poor prognosis in gastrointestinal and non-gastrointestinal cancers. The aim of our study was to test the hypothesis that higher levels of COX-2 expression are prognostically related to poor clinico-pathologic features in adenocarcinoma of the oesophagus. Methods: We reviewed the records of 100 consecutive patients undergoing resection for adenocarcinoma of the eoesophagus to collect data on T-stage, N-stage, tumour recurrence and survival. T & N-stage was further confirmed by histological examination. COX-2 protein expression was assessed by immuncihistochemistry in all patients and COX-2 m-RNA expression was measured by quantitative RT-PCR in a small group of patients. Results: Higher levels of COX-2 expression were associated with higher T stage (p = 0.008), higher N stage (p = 0.049), increased risk of tumour recurrence (p = 0.01) and poor survival (p = 200 was associated with a median survival of 10 months compared to 26 months with a score of

Original languageEnglish
Article number134
JournalBMC Cancer
Volume6
DOIs
Publication statusPublished - May 19 2006

Fingerprint

Cyclooxygenase 2
Survival
Neoplasms
Recurrence
Adenocarcinoma
Adenocarcinoma Of Esophagus
RNA
Polymerase Chain Reaction
Proteins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bhandari, P., Bateman, A. C., Mehta, R. L., Stacey, B. S. F., Johnson, P., Cree, I. A., ... Patel, P. (2006). Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. BMC Cancer, 6, [134]. https://doi.org/10.1186/1471-2407-6-134

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. / Bhandari, Pradeep; Bateman, Adrian C.; Mehta, Raj L.; Stacey, Bernard S F; Johnson, Penny; Cree, Ian A.; Di Nicolantonio, Federica; Patel, Praful.

In: BMC Cancer, Vol. 6, 134, 19.05.2006.

Research output: Contribution to journalArticle

Bhandari, Pradeep ; Bateman, Adrian C. ; Mehta, Raj L. ; Stacey, Bernard S F ; Johnson, Penny ; Cree, Ian A. ; Di Nicolantonio, Federica ; Patel, Praful. / Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. In: BMC Cancer. 2006 ; Vol. 6.
@article{9cec61a03691408386b9ca7e220feb3b,
title = "Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus",
abstract = "Background: COX-2 expression in tumour cells has been associated with poor prognosis in gastrointestinal and non-gastrointestinal cancers. The aim of our study was to test the hypothesis that higher levels of COX-2 expression are prognostically related to poor clinico-pathologic features in adenocarcinoma of the oesophagus. Methods: We reviewed the records of 100 consecutive patients undergoing resection for adenocarcinoma of the eoesophagus to collect data on T-stage, N-stage, tumour recurrence and survival. T & N-stage was further confirmed by histological examination. COX-2 protein expression was assessed by immuncihistochemistry in all patients and COX-2 m-RNA expression was measured by quantitative RT-PCR in a small group of patients. Results: Higher levels of COX-2 expression were associated with higher T stage (p = 0.008), higher N stage (p = 0.049), increased risk of tumour recurrence (p = 0.01) and poor survival (p = 200 was associated with a median survival of 10 months compared to 26 months with a score of",
author = "Pradeep Bhandari and Bateman, {Adrian C.} and Mehta, {Raj L.} and Stacey, {Bernard S F} and Penny Johnson and Cree, {Ian A.} and {Di Nicolantonio}, Federica and Praful Patel",
year = "2006",
month = "5",
day = "19",
doi = "10.1186/1471-2407-6-134",
language = "English",
volume = "6",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus

AU - Bhandari, Pradeep

AU - Bateman, Adrian C.

AU - Mehta, Raj L.

AU - Stacey, Bernard S F

AU - Johnson, Penny

AU - Cree, Ian A.

AU - Di Nicolantonio, Federica

AU - Patel, Praful

PY - 2006/5/19

Y1 - 2006/5/19

N2 - Background: COX-2 expression in tumour cells has been associated with poor prognosis in gastrointestinal and non-gastrointestinal cancers. The aim of our study was to test the hypothesis that higher levels of COX-2 expression are prognostically related to poor clinico-pathologic features in adenocarcinoma of the oesophagus. Methods: We reviewed the records of 100 consecutive patients undergoing resection for adenocarcinoma of the eoesophagus to collect data on T-stage, N-stage, tumour recurrence and survival. T & N-stage was further confirmed by histological examination. COX-2 protein expression was assessed by immuncihistochemistry in all patients and COX-2 m-RNA expression was measured by quantitative RT-PCR in a small group of patients. Results: Higher levels of COX-2 expression were associated with higher T stage (p = 0.008), higher N stage (p = 0.049), increased risk of tumour recurrence (p = 0.01) and poor survival (p = 200 was associated with a median survival of 10 months compared to 26 months with a score of

AB - Background: COX-2 expression in tumour cells has been associated with poor prognosis in gastrointestinal and non-gastrointestinal cancers. The aim of our study was to test the hypothesis that higher levels of COX-2 expression are prognostically related to poor clinico-pathologic features in adenocarcinoma of the oesophagus. Methods: We reviewed the records of 100 consecutive patients undergoing resection for adenocarcinoma of the eoesophagus to collect data on T-stage, N-stage, tumour recurrence and survival. T & N-stage was further confirmed by histological examination. COX-2 protein expression was assessed by immuncihistochemistry in all patients and COX-2 m-RNA expression was measured by quantitative RT-PCR in a small group of patients. Results: Higher levels of COX-2 expression were associated with higher T stage (p = 0.008), higher N stage (p = 0.049), increased risk of tumour recurrence (p = 0.01) and poor survival (p = 200 was associated with a median survival of 10 months compared to 26 months with a score of

UR - http://www.scopus.com/inward/record.url?scp=33745315686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745315686&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-6-134

DO - 10.1186/1471-2407-6-134

M3 - Article

C2 - 16712734

AN - SCOPUS:33745315686

VL - 6

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 134

ER -